“We’re very pure about what we’re doing: we fund the best science for this terrible disease … and we want the results to solve the problem. We want to protect the scientists that we work with—and we want them to collaborate. We’re working at the forefront of science, research, and discovery for Alzheimer’s. If you care about stopping the disease, this is the organization to work with.”
Phyllis Rappaport is Chair of the Phyllis and Jerome Lyle Rappaport Foundation, Boston, MA.
The foundation encourages bright faculty and student talent from the region to improve state and local public policy via the Rappaport Institute at Harvard University and the Rappaport Center at Boston College Law School. The foundation funds Rappaport Research Fellows in neurologic disease and mental illness at three Harvard hospitals, endows the DeCordova’s annual Rappaport Prize for a contemporary artist, and funds Florida’s Rappaport Prize for Music Composition.
Ms. Rappaport is Director of New Boston Fund, Inc., a real estate investment company. Previously she was manager at a Fortune 50 high tech company and a PricewaterhouseCoopers auditor specializing in banking and healthcare.
Ms. Rappaport serves on advisory boards of Harvard Kennedy School, the Massachusetts General Hospital, and McLean Hospital. She was an elected member of the Lincoln-Sudbury Regional School Committee and a longtime Trustee of the DeCordova Sculpture Park and Museum in Lincoln, Massachusetts.
Ms. Rappaport is a founding member and on the Board of Directors of Cure Alzheimer’s Fund.
Ms. Rappaport is a graduate of Smith College and Simmons Graduate School of Management.